trial · primary record
TCP-25 gel
Epidermolysis Bullosa (EB)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 32 |
| Primary completion | 2027-06-30 |
| Primary endpoint | Open wound area |
| Registry ID | NCT06594393 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:04.418Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06594393
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.